GO:0043513 inhibin B complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043513 (inhibin B complex) is a heterodimeric hormone composed of an inhibin alpha subunit complexed with an inhibin beta-B subunit.
• Inhibin B is a more potent suppressor of follicle-stimulating hormone (FSH) release than inhibin A in vitro and in vivo.
• Inhibin B is produced primarily by the gonads and is a key endocrine marker of testicular and ovarian function.
• Inhibin B serves as a potential biomarker of testicular toxicity and is used to assess spermatogenesis in nonobstructive azoospermia.
• In women, inhibin B predicts oocyte yield in expected poor responders and declines during the final phases of ovarian aging.
• Research on inhibin B complex involves endocrine assays, CRISPR knockout models, and reproductive biology studies.
Description
The inhibin B complex (GO:0043513) is a heterodimeric hormone composed of an inhibin alpha subunit complexed with an inhibin beta-B subunit. It is a critical endocrine regulator of follicle-stimulating hormone (FSH) secretion from the pituitary gland. Inhibin B is produced primarily by the gonads and plays a central role in reproductive physiology. Researchers study this complex to understand gonadal function, fertility, and endocrine disorders. Inhibin B is a more potent suppressor of FSH release than inhibin A, making it a key regulator of the hypothalamic-pituitary-gonadal axis. Its measurement is clinically relevant as a biomarker of testicular toxicity and ovarian reserve. In men, inhibin B reflects Sertoli cell function and spermatogenesis, and it is used to evaluate nonobstructive azoospermia. In women, inhibin B levels correlate with oocyte yield and decline during ovarian aging. Understanding the inhibin B complex at the molecular and cellular level is essential for developing diagnostic and therapeutic strategies in reproductive medicine.
inhibin B complex At A Glance
| GO ID | GO:0043513 |
|---|---|
| GO term | inhibin B complex |
| Ontology | cellular_component |
| Synonym | none |
| Major function | Heterodimeric hormone that suppresses FSH release |
| Subunit composition | Inhibin alpha subunit + inhibin beta-B subunit |
| Primary source | Gonads (Sertoli cells, granulosa cells) |
| Clinical relevance | Biomarker of testicular toxicity, ovarian reserve, and azoospermia |
What Is GO:0043513?
The inhibin B complex (GO:0043513) is defined by the Gene Ontology as a heterodimeric hormone composed of an inhibin alpha subunit complexed with an inhibin beta-B subunit. This complex is a secreted protein with endocrine functions, primarily acting to suppress FSH release from the anterior pituitary. The complex is assembled from two distinct gene products: the inhibin alpha subunit (INHA) and the inhibin beta-B subunit (INHBB). The heterodimer is stabilized by disulfide bonds and circulates in the bloodstream.
Why Is inhibin B complex Important in Cell Biology?
The inhibin B complex is essential for reproductive endocrine regulation, as it is a more potent suppressor of FSH release than inhibin A. Its measurement provides critical information about gonadal function in both males and females. In men, inhibin B is a biomarker of testicular toxicity and spermatogenesis, aiding in the diagnosis of nonobstructive azoospermia. In women, inhibin B predicts oocyte yield in poor responders and reflects ovarian aging. Thus, understanding the inhibin B complex has direct clinical implications for fertility assessment and reproductive medicine.
• Regulates FSH secretion as a potent endocrine suppressor.
• Serves as a biomarker of testicular toxicity and Sertoli cell function.
• Aids in the evaluation of nonobstructive azoospermia.
• Predicts oocyte yield in expected poor responders undergoing IVF.
• Declines during the final phases of ovarian aging.
• Involved in the neuroendocrinology of menopause.
• Relevant to NR0B1-related adrenal hypoplasia congenita.
• Associated with myotonic dystrophy type 2 endocrine features.
• Provides a model for studying heterodimeric hormone assembly.
• Target for CRISPR-based functional studies in reproductive biology.
Structure and Composition of inhibin B complex
Inhibin alpha subunit (INHA)
In simple terms: The alpha subunit is one half of the inhibin B hormone.
The inhibin alpha subunit is encoded by the INHA gene and forms a disulfide-linked heterodimer with the inhibin beta-B subunit. It is essential for the assembly and stability of the inhibin B complex.
Inhibin beta-B subunit (INHBB)
In simple terms: The beta-B subunit is the other half of the inhibin B hormone.
The inhibin beta-B subunit is encoded by the INHBB gene and combines with the alpha subunit to form the mature inhibin B complex. This subunit confers specificity for FSH suppression.
Heterodimer assembly
In simple terms: The two subunits join together to form the active hormone.
The inhibin B complex is assembled through disulfide bond formation between the alpha and beta-B subunits. This heterodimer is secreted and circulates as a functional hormone.
Gonadal expression
In simple terms: Inhibin B is made mainly in the gonads.
Inhibin B is produced primarily by Sertoli cells in the testes and granulosa cells in the ovaries. Its expression is regulated by endocrine signals and reflects gonadal activity.
Secreted hormone complex
In simple terms: Inhibin B acts as a hormone in the bloodstream.
The inhibin B complex is secreted into the circulation and acts on the pituitary to suppress FSH release. It is a more potent suppressor of FSH than inhibin A.
Key Genes Involved in GO:0043513 inhibin B complex
The following genes and proteins are directly involved in the structure, regulation, and function of the inhibin B complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| INHA | Encodes inhibin alpha subunit | Essential for inhibin B assembly |
| INHBB | Encodes inhibin beta-B subunit | Confers FSH suppression specificity |
| FSHB | Encodes FSH beta subunit | Target of inhibin B feedback |
| NR0B1 | Adrenal hypoplasia congenita gene | Associated with endocrine dysfunction |
| DMPK | Myotonic dystrophy type 2 related | Endocrine features may involve inhibin B |
| CGA | Glycoprotein hormone alpha subunit | Related to gonadotropin function |
| LHB | Luteinizing hormone beta subunit | Gonadotropin regulation |
| GNRHR | GnRH receptor | Upstream regulator of gonadotropins |
| ESR1 | Estrogen receptor alpha | Ovarian function and inhibin B |
| ESR2 | Estrogen receptor beta | Ovarian aging and inhibin B |
| AMH | Anti-Mullerian hormone | Ovarian reserve marker |
| CYP19A1 | Aromatase | Estrogen synthesis in gonads |
| SOX9 | Sertoli cell marker | Testicular function |
| DAZL | Germ cell marker | Spermatogenesis |
| WT1 | Wilms tumor 1 | Gonadal development |
| SF1 | Steroidogenic factor 1 | Adrenal and gonadal function |
| GATA4 | Transcription factor | Gonadal development |
How Is inhibin B complex Regulated?
The inhibin B complex is regulated at multiple levels, including gonadal production and endocrine feedback. Inhibin B is a more potent suppressor of FSH release than inhibin A, indicating its central role in the negative feedback loop of the hypothalamic-pituitary-gonadal axis. Its levels are influenced by gonadal function, as seen in conditions such as nonobstructive azoospermia and ovarian aging. In women, inhibin B levels decline during the final phases of ovarian aging, reflecting reduced follicular activity. Additionally, inhibin B is a biomarker of testicular toxicity, suggesting that its production is sensitive to gonadal damage. The regulation of inhibin B is also relevant in neuroendocrinology of menopause and in NR0B1-related adrenal hypoplasia congenita.
inhibin B complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| INHA | Inhibin B deficiency | KO mouse model |
| INHBB | FSH dysregulation | KO mouse model |
| NR0B1 | Adrenal hypoplasia congenita | Knock-in mouse |
| DMPK | Myotonic dystrophy type 2 | Overexpression model |
| FSHB | Gonadotropin deficiency | Point mutation model |
Inhibin B and testicular toxicity
Inhibin B is a potential biomarker of testicular toxicity, as it reflects Sertoli cell function and spermatogenesis. Reduced inhibin B levels are associated with testicular damage and impaired fertility. In nonobstructive azoospermia, inhibin B is used to assess endocrine aberrations and spermatogenic failure.
Inhibin B and ovarian aging
Inhibin B levels decline during the final phases of ovarian aging, making it a marker of ovarian reserve. It predicts oocyte yield in expected poor responders undergoing assisted reproduction. These findings highlight the clinical utility of inhibin B in reproductive medicine.
Inhibin B in endocrine disorders
Inhibin B is relevant to neuroendocrinology of menopause, where it contributes to the regulation of FSH. It is also associated with NR0B1-related adrenal hypoplasia congenita, a disorder affecting adrenal and gonadal function. Additionally, myotonic dystrophy type 2 may present with endocrine features involving inhibin B.
From inhibin B complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Role of inhibin B in FSH suppression | INHBB knockout mouse |
| Inhibin B as testicular toxicity biomarker | Rodent toxicity model |
| Inhibin B in ovarian aging | Aged mouse model |
| Inhibin B in azoospermia | Human clinical samples |
| Inhibin B in adrenal hypoplasia | NR0B1 knockout mouse |
| Inhibin B in myotonic dystrophy | DMPK overexpression model |
How to Study the inhibin B complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ELISA | Inhibin B protein levels | Clinical biomarker assessment |
| CRISPR knockout | Gene function | INHA/INHBB knockout models |
| RNA-seq | Gene expression changes | Gonadal transcriptomics |
| Proteomics | Protein interactions | Complex assembly studies |
| Immunohistochemistry | Tissue localization | Sertoli/granulosa cell detection |
| FSH suppression assay | Hormone feedback | Pituitary cell culture |
| Ovarian reserve testing | Inhibin B correlation | IVF prognosis |
Endocrine assays for inhibin B
Inhibin B levels are measured using immunoassays, such as ELISA, to assess gonadal function and FSH suppression. These assays are used in clinical studies of testicular toxicity and ovarian reserve.
CRISPR knockout models
CRISPR/Cas9 knockout of INHA or INHBB can be used to study the role of the inhibin B complex in FSH regulation and gonadal function. These models help determine the causal role of inhibin B in reproductive physiology.
Transcriptomic and proteomic analysis
RNA-seq and proteomics can identify downstream targets and interacting partners of the inhibin B complex. These methods reveal molecular changes in gonadal tissues under different endocrine conditions.
Clinical biomarker studies
Inhibin B is evaluated as a biomarker in clinical settings, including prediction of oocyte yield and assessment of azoospermia. These studies correlate inhibin B levels with reproductive outcomes.
How CRISPR Can Be Used to Study GO:0043513 inhibin B complex
Knockout
CRISPR knockout of INHA or INHBB can abolish inhibin B complex formation, leading to increased FSH levels and gonadal dysfunction. These models are essential for studying the causal role of inhibin B in reproductive endocrine regulation.
Point Mutation
Point mutations in INHA or INHBB can be introduced to mimic human variants and study their impact on heterodimer assembly and FSH suppression. Such models help dissect structure-function relationships.
Knock-in
Knock-in of tagged INHA or INHBB allows visualization and tracking of the inhibin B complex in vivo. This approach facilitates studies of complex trafficking and secretion.
Overexpression
Overexpression of INHA and INHBB can model elevated inhibin B levels and their effects on FSH suppression and gonadal function. These models are useful for studying endocrine feedback.
How EDITGENE Supports inhibin B complex Research
Researchers studying inhibin B complex-related genes often need to determine whether a candidate gene is causally involved in gonadal function, FSH regulation, or reproductive disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for inhibin B complex research.
Frequently Asked Questions About inhibin B complex
What is the inhibin B complex?
The inhibin B complex (GO:0043513) is a heterodimeric hormone composed of an inhibin alpha subunit and an inhibin beta-B subunit.
What genes are involved in the inhibin B complex?
The main genes are INHA (alpha subunit) and INHBB (beta-B subunit).
What is the function of inhibin B?
Inhibin B suppresses follicle-stimulating hormone (FSH) release and is a more potent suppressor than inhibin A.
Where is inhibin B produced?
Inhibin B is produced primarily in the gonads, including Sertoli cells in testes and granulosa cells in ovaries.
How is inhibin B used as a biomarker?
Inhibin B is a biomarker of testicular toxicity, ovarian reserve, and oocyte yield in poor responders.
What diseases are associated with inhibin B?
Inhibin B is associated with nonobstructive azoospermia, ovarian aging, and adrenal hypoplasia congenita.
How can I study the inhibin B complex using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to study INHA and INHBB function.
What is the GO ID for inhibin B complex?
The GO ID is GO:0043513.
Is inhibin B more potent than inhibin A?
Yes, inhibin B is a more potent suppressor of FSH release than inhibin A in vitro and in vivo.
What are the research methods for inhibin B?
Common methods include ELISA, CRISPR knockout, RNA-seq, and proteomics.
Conclusion
The inhibin B complex (GO:0043513) is a critical heterodimeric hormone that regulates FSH secretion and serves as a key biomarker in reproductive medicine. Its roles in testicular toxicity, azoospermia, and ovarian aging underscore its clinical importance. CRISPR-based models and advanced bioinformatics are essential tools for dissecting its function and regulation. EDITGENE provides comprehensive services to support research on the inhibin B complex and related genes.
References
- 1. Stewart J et al.. 2005. Inhibin B as a potential biomarker of testicular toxicity.. Cancer Biomark 1(1):75-91 PMID: 17192034
- 2. Adam MP et al.. 1993. Myotonic Dystrophy Type 2.. PMID: 20301639
- 3. Tao Y. 2022. Endocrine aberrations of human nonobstructive azoospermia.. Asian J Androl 24(3):274-286 PMID: 35042310
- 4. Dasgupta A et al.. 2006. Neuroendocrinology of menopause.. Minerva Ginecol 58(1):25-33 PMID: 16498368
- 5. Melado L et al.. 2025. The role of bioavailable inhibin B in predicting oocyte yield in expected poor responders: the forgotten marker?. J Assist Reprod Genet 42(11):3913-3920 PMID: 40866738
- 6. Makanji Y et al.. 2009. Inhibin B is a more potent suppressor of rat follicle-stimulating hormone release than inhibin a in vitro and in vivo.. Endocrinology 150(10):4784-93 PMID: 19589860
- 7. Adam MP et al.. 1993. NR0B1-Related Adrenal Hypoplasia Congenita.. PMID: 20301604
- 8. Bochynska S et al.. 2025. The Final Phases of Ovarian Aging: A Tale of Diverging Functional Trajectories.. J Clin Med 14(16) PMID: 40869659
